The successful campaign of adoptive T cell therapies, a type of immunotherapy in which immune T cells are collected from a patient, enhanced outside of the body, and reinfused back into the same patient, especially against blood cancers is well under way.
Optimizing MIPS Value Pathways (MVPs) for Oncology Practices
Erin Crum, Sr. Director of Quality Strategy and Innovation, The US Oncology Network and McKesson The Centers for Medicare and Medicaid Services (CMS) introduced the
December 12, 2024